Press release
Future of RNAi Therapeutics: Small Interfering RNAs, MicroRNAs, and Targeted Treatment Opportunities through 2031 | Silence Therapeutics, Arrowhead Pharmaceuticals, Inc, Sanofi.
RNAi Therapeutics Market
The RNAi therapeutics market includes drugs that use RNA interference mechanisms to silence specific genes responsible for disease. These therapies offer precision treatment options for cancers, viral infections, and genetic disorders. Market growth is driven by increasing investment in biotechnology, rising prevalence of target diseases, and clinical trial advancements. Delivery systems such as lipid nanoparticles and conjugates are improving therapeutic efficacy. Regulatory approvals and emerging pipelines are accelerating commercialization. Personalized medicine and gene-targeted therapy trends are further expanding market potential.
📌 Download Sample Report to Identify Emerging Deals & Opportunities in the RNAi Therapeutics Market Landscape:- https://datamintelligence.com/download-sample/rnai-therapeutics-market?rk
☛ RNAi Therapeutics Market Recent Developments 2025:
United States: Recent Industry Developments
✅ In August 2025, Alnylam Pharmaceuticals expanded RNAi-based therapeutics, targeting rare genetic diseases.
✅ In July 2025, Arrowhead Pharmaceuticals launched next-gen RNAi therapies, supporting precision medicine.
✅ In June 2025, Dicerna Pharmaceuticals partnered with hospitals to implement RNAi therapeutics programs, improving patient outcomes.
Europe: Recent Industry Developments
✅ In July 2025, Alnylam Europe introduced novel RNAi therapies, advancing treatment for liver and genetic disorders.
✅ In June 2025, Arrowhead Europe expanded clinical programs for RNAi-based drugs.
✅ In May 2025, Dicerna Europe partnered with hospitals to deploy RNAi therapeutic solutions, enhancing personalized medicine.
Japan: Recent Industry Developments
✅ In July 2025, Takeda Pharmaceutical Japan launched RNAi therapeutics for genetic and rare diseases.
✅ In June 2025, Daiichi Sankyo expanded RNAi therapy development programs.
✅ In May 2025, Astellas Pharma partnered with hospitals to implement RNAi-based treatment strategies, supporting precision medicine initiatives.
☛ RNAi Therapeutics Market Trends:
RNA interference (RNAi) therapeutics target specific genes to silence disease-causing mRNA, offering precision medicine solutions. Growth is driven by advancements in delivery technologies, increasing prevalence of genetic disorders, and clinical pipeline expansion.
Trends include nanoparticle delivery systems, personalized RNAi therapies, and combination treatments. North America dominates due to biotech leadership, while Asia-Pacific grows with increasing R&D investment and clinical trials. Challenges include delivery efficiency, immune response, and high development costs.
☛ RNAi Therapeutics Market Competitve Landscape:
Alnylam Pharmaceuticals, Inc, Dicerna Pharmaceuticals, Silence Therapeutics, Arrowhead Pharmaceuticals, Inc, Sanofi, GlaxoSmithKline Plc, Arbutus Biopharma Corporation, Benitec Biopharma, Thermo Fisher Scientific Inc and Sirnaomics, Inc.
Research Methodology
We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.
📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/rnai-therapeutics-market
☛ Segment Covered in the RNAi Therapeutics Market:
By Type: Small Interfering RNAs (siRNA), MicroRNA (miRNA).
By Application: Oncology, Cardiovascular, Respiratory Disorders, Renal Diseases, Genetic Disorders, Neurodegenerative Disorders, Infectious Diseases, Others.
By Route of Administration: Pulmonary Delivery, Intravenous Injections, Intradermal Injections, Intraperitoneal Injections, Others.
By End-User: Hospitals, Research and Academic Laboratories, Diagnostic Laboratories.
☛ This Report Includes:
✔ Comprehensive go-to-market strategies with actionable insights.
✔ Unbiased evaluation of overall market performance.
✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.
✔ Tailored regional and country-level reports with detailed localized analysis available on request.
✔ Identification of niche segments and high-growth regions presenting strong opportunities.
✔ Accurate regional forecasts using both top-down and bottom-up approaches.
📌 Get Corporate Access to Live RNAi Therapeutics Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=rnai-therapeutics-market
☛ Regional Analysis for RNAi Therapeutics Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Future of RNAi Therapeutics: Small Interfering RNAs, MicroRNAs, and Targeted Treatment Opportunities through 2031 | Silence Therapeutics, Arrowhead Pharmaceuticals, Inc, Sanofi. here
News-ID: 4207659 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Femtech Market to Reach US$ 112.30 Billion by 2033, Driven by Rising Awareness o …
The Global Femtech Market reached US$ 38.90 billion in 2024 and is expected to reach US$ 112.30 billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033.
According to DataM Intelligence has published a new research report on "Femtech Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers.…
United States Petrochemicals Market Expected to Grow at 5.8% CAGR Through 2031, …
Leander, Texas and Tokyo, Japan - Jan.09.2026,As per DataM intelligence research report "Petrochemicals market size is estimated to reach USD million by 2031, growing at a CAGR of 6% during the forecast period 2024-2031." Rising demand for plastics, synthetic fibers, and specialty chemicals, coupled with expanding end-use industries and capacity additions in Asia, continues to drive the petrochemicals sector despite energy transition pressures.
Download your exclusive sample report today: (corporate email…
Quantum Chip Market to Skyrocket to US$ 4.96 Billion by 2031 at 52.6% CAGR | Top …
Global Quantum Chip Market reached US$ 168.7 Million in 2023 and is expected to reach US$ 4960.8 Million by 2031, growing with a CAGR of 52.6% during the forecast period 2024-2031.
According to DataM Intelligence has published a new research report on "Quantum Chip Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and…
United States EV Charging Cable Market Projected to Reach US$ 3.2 Billion by 203 …
Leander, Texas and Tokyo, Japan - Jan.09.2026,As per DataM intelligence research report "The EV Charging Cable Market reached US$ 1.56 billion in 2024 and is expected to reach US$ 8.50 billion by 2033, growing at a CAGR of 20.7% during the forecast period 2025-2033." Rising electric vehicle adoption, fast-charging infrastructure expansion, and innovations in durable, high power cables are propelling demand for advanced EV charging solutions.
Download your exclusive sample report…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
